rotate-mobile
Venerdì, 29 Marzo 2024
Salute

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases



In Evidenza

Potrebbe interessarti

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases

Today è in caricamento